annual CFF:
$343.88M+$309.54M(+901.23%)Summary
- As of today (June 27, 2025), IMCR annual cash flow from financing activities is $343.88 million, with the most recent change of +$309.54 million (+901.23%) on December 31, 2024.
- During the last 3 years, IMCR annual CFF has risen by +$55.70 million (+19.33%).
- IMCR annual CFF is now at all-time high.
Performance
IMCR Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$2.55M+$54.06M(+104.95%)Summary
- As of today (June 27, 2025), IMCR quarterly cash flow from financing activities is $2.55 million, with the most recent change of +$54.06 million (+104.95%) on March 31, 2025.
- Over the past year, IMCR quarterly CFF has dropped by -$393.46 million (-99.36%).
- IMCR quarterly CFF is now -99.36% below its all-time high of $396.01 million, reached on March 31, 2024.
Performance
IMCR quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$49.58M-$393.46M(-114.42%)Summary
- As of today (June 27, 2025), IMCR TTM cash flow from financing activities is -$49.58 million, with the most recent change of -$393.46 million (-114.42%) on March 31, 2025.
- Over the past year, IMCR TTM CFF has dropped by -$473.80 million (-111.69%).
- IMCR TTM CFF is now -111.69% below its all-time high of $424.22 million, reached on March 31, 2024.
Performance
IMCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMCR Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +901.2% | -99.4% | -111.7% |
| 3 y3 years | +19.3% | +245.8% | -3570.4% |
| 5 y5 years | +375.8% | -92.1% | -253.3% |
IMCR Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +901.2% | -99.4% | +105.0% | -111.7% | at low |
| 5 y | 5-year | at high | +901.2% | -99.4% | +105.0% | -111.7% | at low |
| alltime | all time | at high | >+9999.0% | -99.4% | +105.0% | -111.7% | at low |
IMCR Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.55M(-105.0%) | -$49.58M(-114.4%) |
| Dec 2024 | $343.88M(+901.2%) | -$51.51M(<-9900.0%) | $343.88M(-14.4%) |
| Sep 2024 | - | $198.00K(-124.2%) | $401.65M(-2.5%) |
| Jun 2024 | - | -$818.00K(-100.2%) | $411.82M(-2.9%) |
| Mar 2024 | - | $396.01M(+6232.1%) | $424.22M(+1135.1%) |
| Dec 2023 | $34.35M(-76.4%) | $6.25M(-39.7%) | $34.35M(-22.6%) |
| Sep 2023 | - | $10.38M(-10.4%) | $44.39M(-73.2%) |
| Jun 2023 | - | $11.58M(+88.6%) | $165.43M(+7.9%) |
| Mar 2023 | - | $6.14M(-62.3%) | $153.33M(+5.4%) |
| Dec 2022 | $145.44M | $16.30M(-87.6%) | $145.44M(+4.0%) |
| Sep 2022 | - | $131.41M(<-9900.0%) | $139.80M(-8699.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$518.40K(-70.4%) | -$1.63M(+20.4%) |
| Mar 2022 | - | -$1.75M(-116.4%) | -$1.35M(-100.5%) |
| Dec 2021 | $288.19M(+82.4%) | $10.66M(-206.4%) | $288.19M(-28.8%) |
| Sep 2021 | - | -$10.02M(+4014.7%) | $404.69M(-2.4%) |
| Jun 2021 | - | -$243.50K(-100.1%) | $414.71M(+0.3%) |
| Mar 2021 | - | $287.79M(+126.3%) | $413.45M(+161.7%) |
| Dec 2020 | $158.01M(+118.6%) | $127.16M(>+9900.0%) | $158.01M(+412.3%) |
| Sep 2020 | - | $5900.00(-100.4%) | $30.84M(+0.0%) |
| Jun 2020 | - | -$1.51M(-104.7%) | $30.84M(-4.7%) |
| Mar 2020 | - | $32.35M | $32.35M |
| Dec 2019 | $72.28M(>+9900.0%) | - | - |
| Dec 2018 | $128.20K | - | - |
FAQ
- What is Immunocore Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Immunocore Holdings?
- What is Immunocore Holdings annual CFF year-on-year change?
- What is Immunocore Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Immunocore Holdings?
- What is Immunocore Holdings quarterly CFF year-on-year change?
- What is Immunocore Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Immunocore Holdings?
- What is Immunocore Holdings TTM CFF year-on-year change?
What is Immunocore Holdings annual cash flow from financing activities?
The current annual CFF of IMCR is $343.88M
What is the all time high annual CFF for Immunocore Holdings?
Immunocore Holdings all-time high annual cash flow from financing activities is $343.88M
What is Immunocore Holdings annual CFF year-on-year change?
Over the past year, IMCR annual cash flow from financing activities has changed by +$309.54M (+901.23%)
What is Immunocore Holdings quarterly cash flow from financing activities?
The current quarterly CFF of IMCR is $2.55M
What is the all time high quarterly CFF for Immunocore Holdings?
Immunocore Holdings all-time high quarterly cash flow from financing activities is $396.01M
What is Immunocore Holdings quarterly CFF year-on-year change?
Over the past year, IMCR quarterly cash flow from financing activities has changed by -$393.46M (-99.36%)
What is Immunocore Holdings TTM cash flow from financing activities?
The current TTM CFF of IMCR is -$49.58M
What is the all time high TTM CFF for Immunocore Holdings?
Immunocore Holdings all-time high TTM cash flow from financing activities is $424.22M
What is Immunocore Holdings TTM CFF year-on-year change?
Over the past year, IMCR TTM cash flow from financing activities has changed by -$473.80M (-111.69%)